Why is Strides Pharma falling/rising?

As of 29-Oct, Strides Pharma Science Ltd is experiencing a price increase, currently at 850.00, reflecting a rise of 36.45 or 4.48%. The stock has shown strong performance today, outperforming its sector by 3.74% and achieving a consecutive gain over the last two days with a total return of 4.49%. It reached an intraday high of Rs 868, indicating positive momentum. Over the past week, the stock has increased by 5.27%, and year-to-date, it has delivered a remarkable return of 29.26%. Despite these gains, there has been a decline in investor participation, with delivery volume falling by 11.31% against the 5-day average. The company has reported positive results for the last eight consecutive quarters, with strong operating cash flow and a low debt-equity ratio, contributing to its attractive valuation compared to peers. In the broader market context, Strides Pharma's short-term performance has significantly outpaced the benchmark, with a 1-week return of 5.27% compared to the Sensex's 0.68%. While the stock has generated an 18.77% return over the past year, it is important to note that its profits have decreased by 19.9%, which may raise concerns among investors. Nevertheless, the stock's consistent returns over the last three years, coupled with its ability to outperform the BSE500 in each of the last three annual periods, suggest a resilient performance amidst broader market fluctuations.